Addition of PD-L1 Antibody MEDI4736 to a Taxane-anthracycline Chemotherapy in Triple Negative Breast Cancer
Clinical trial NCT02685059 · COMPLETED
Trial details
- NCT number
- NCT02685059
- Sponsor
- GBG Forschungs GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2018-03-01
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.